ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Prostate Cancer trials near Portland, OR, USA:

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer (PROSPECTOR)

(PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer...

Enrolling
Metastatic Prostate Cancer
Drug: AZD2287 (Imaging agent)
Drug: Docetaxel

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Portland, Oregon, United States and 34 other locations

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Drug: valacyclovir

Phase 2

Candel Therapeutics

Portland, Oregon, United States and 22 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Active, not recruiting
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Portland, Oregon, United States and 13 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Active, not recruiting
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Portland, Oregon, United States and 42 other locations

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Portland, Oregon, United States and 12 other locations

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...

Active, not recruiting
Prostate Cancer
Biological: Placebo + valacyclovir
Biological: Aglatimagene besadenovec + valacyclovir

Phase 3

Candel Therapeutics

Portland, Oregon, United States and 73 other locations

with abiraterone acetate plus prednisone has on the patient and the prostate cancer. Abiraterone acetate plus prednisone are drugs ...

Active, not recruiting
Prostate Cancer
Drug: Ipilimumab

Phase 1, Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Portland, Oregon, United States and 2 other locations

All patients will be required to have a biopsy of a metastatic tumor deposit at study entry. Pembrolizumab will be administered at a dose of...

Enrolling
Prostate Cancer Metastatic
Prostate Cancer
Biological: Fecal microbiota transplant
Drug: Pembrolizumab

Phase 2

Julie Graff, MD

Portland, Oregon, United States

The main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: AZD2284
Drug: AZD2275

Phase 1

AstraZeneca
AstraZeneca

Portland, Oregon, United States and 15 other locations

This clinical trial investigates the change in prostate-specific membrane antigen (PSMA) expression in response to hormonal therapy in both, ...

Enrolling
Prostate Adenocarcinoma
Castration Sensitive Prostate Cancer
Other: Electronic Health Record Review
Drug: Piflufolastat

Phase 4

OHSU Knight Cancer Institute
OHSU Knight Cancer Institute

Portland, Oregon, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems